Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.29 USD | -2.17% | -4.90% | +31.52% |
Financials (USD)
Sales 2024 * | 64.29M | Sales 2025 * | 115M | Capitalization | 1.65B |
---|---|---|---|---|---|
Net income 2024 * | -317M | Net income 2025 * | -360M | EV / Sales 2024 * | 24.5 x |
Net cash position 2024 * | 68.82M | Net Debt 2025 * | 36.47M | EV / Sales 2025 * | 14.7 x |
P/E ratio 2024 * |
-5.36
x | P/E ratio 2025 * |
-4.99
x | Employees | 385 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.03% |
Latest transcript on Agios Pharmaceuticals, Inc.
1 day | -2.17% | ||
1 week | -4.90% | ||
Current month | -9.38% | ||
1 month | +10.49% | ||
3 months | +25.98% | ||
6 months | +15.04% | ||
Current year | +31.52% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Goff
CEO | Chief Executive Officer | 55 | 22-08-07 |
Cecilia Jones
DFI | Director of Finance/CFO | 49 | 22-09-25 |
Jacqualyn Fouse
CHM | Chairman | 62 | 17-12-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Capello
BRD | Director/Board Member | 69 | 23-05-31 |
Director/Board Member | 64 | 14-12-08 | |
May Kin Ho
BRD | Director/Board Member | 71 | 15-06-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.52% | 1 M€ | -.--% | - | |
0.16% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.06% | 464 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 29.29 | -2.17% | 654,650 |
24-03-15 | 29.94 | +1.63% | 1,340,994 |
24-03-14 | 29.46 | -1.80% | 539,440 |
24-03-13 | 30 | -0.96% | 518,166 |
24-03-12 | 30.29 | -1.66% | 518,058 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.52% | 1.65B | |
+1.10% | 106B | |
+9.29% | 103B | |
-3.00% | 21.44B | |
-11.89% | 22.11B | |
-26.59% | 20.99B | |
-5.20% | 19.44B | |
-6.58% | 17.6B | |
+5.83% | 13.88B | |
+7.46% | 11.75B |